Skip Navigation LinksHome > January 2013 - Volume 35 - Issue 1 > Prolonged Survival After Treatment of Diffuse Intrinsic Pont...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e318279aed8
Online Articles: Clinical and Laboratory Observations

Prolonged Survival After Treatment of Diffuse Intrinsic Pontine Glioma with Radiation, Temozolamide, and Bevacizumab: Report of 2 Cases

Aguilera, Dolly G. MD; Mazewski, Claire MD; Hayes, Laura MD; Jordan, Cathy CPNP; Esiashivilli, Natia MD; Janns, Anna MD, PhD; MacDonald, Tobey J. MD

Collapse Box


Background: Diffuse intrinsic pontine gliomas have poor prognosis.

Observation: We report on 2 patients with diffuse intrinsic pontine glioma treated with radiation, followed by temozolamide 200 mg/m2/d for 5 days every 28 days and bevacizumab 10 mg/kg/dose every 14 days. Both patients have ongoing PFS of 37 and 47 months from diagnosis. A decrease in tumor size by >65% was observed in both the patients. Both patients continue treatment. No steroid requirement since 10 weeks after radiation. Quality of life is excellent and the chemotherapy regimen is well tolerated.

Conclusions: A clinical trial in an expanded cohort is warranted to determine the toxicity and evaluate response.

Copyright © 2013 Wolters Kluwer Health, Inc. All rights reserved.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us


For additional oncology content, visit LWW Oncology Journals on Facebook.